Literature DB >> 20566125

CE-MR Angiography at 3.0 T Magnetic Field in the Study of Spinal Dural Arteriovenous Fistula. Preliminary Results.

L Albini Riccioli1, A F Marliani, P Ghedin, R Agati, M Leonardi.   

Abstract

SUMMARY: We report technical data and results in eight patients studied with spinal contrast-enhanced MR angiography (CE-MRA). We used a 3.0 Tesla device, dedicated phased array coil and time resolved imaging of contrast kinetics (TRICKS) sequences to visualize the feeder vessels in patients with vascular malformations. TRICKS is a method of 3D CE-MRA providing temporal information. Thanks to its high temporal and spatial resolution and high signal/noise ratio the TRICKS optimized sequence at 3.0 T yielded very encouraging results in disclosing the origin of arteriovenous malformations.

Entities:  

Year:  2007        PMID： 20566125      PMCID： PMC3329162          DOI： 10.1177/159101990701300102

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


  21 in total

1.  Breath-hold contrast-enhanced three-dimensional MR angiography of the abdomen: time-resolved imaging versus single-phase imaging.

Authors:  L Van Hoe; T De Jaegere; H Bosmans; L Stockx; D Vanbeckevoort; R Oyen; R Fagard; G Marchal
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

2.  Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography--initial results.

Authors:  T F Hany; T J Carroll; R A Omary; E Esparza-Coss; F R Korosec; C A Mistretta; T M Grist
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

3.  Arteriographic complications in the DSA era.

Authors:  J R Waugh; N Sacharias
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

4.  Spinal vascular malformations: MR angiography after treatment.

Authors:  M Mascalchi; G Ferrito; N Quilici; S Mangiafico; M Cosottini; M Cellerini; L S Politi; L Guerrini; C Bartolozzi; N Villari
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

Review 5.  X-ray digital subtraction angiography to magnetic resonance-digital subtraction angiography using three-dimensional TRICKS. Historical perspective and computer simulations: a review.

Authors:  C A Mistretta; T M Grist
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

6.  3D time-resolved contrast-enhanced MR DSA: advantages and tradeoffs.

Authors:  C A Mistretta; T M Grist; F R Korosec; R Frayne; D C Peters; Y Mazaheri; T J Carrol
Journal:  Magn Reson Med       Date:  1998-10       Impact factor: 4.668

7.  MR angiography of normal intradural vessels of the thoracolumbar spine.

Authors:  B C Bowen; S DePrima; P M Pattany; A Marcillo; P Madsen; R M Quencer
Journal:  AJNR Am J Neuroradiol       Date:  1996-03       Impact factor: 3.825

8.  Time-resolved contrast-enhanced 3D MR angiography.

Authors:  F R Korosec; R Frayne; T M Grist; C A Mistretta
Journal:  Magn Reson Med       Date:  1996-09       Impact factor: 4.668

9.  Spinal cord vascular disease: characterization with fast three-dimensional contrast-enhanced MR angiography.

Authors:  C A Binkert; S S Kollias; A Valavanis
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

10.  The effect of injection rate on time-resolved contrast-enhanced peripheral MRA.

Authors:  T J Carroll; F R Korosec; J S Swan; T F Hany; T M Grist; C A Mistretta
Journal:  J Magn Reson Imaging       Date:  2001-10       Impact factor: 4.813
View more
  2 in total

Review 1.  Clinical utility of optimized three-dimensional T1-, T2-, and T2*-weighted sequences in spinal magnetic resonance imaging.

Authors:  Nobuko Tanitame; Keizo Tanitame; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2017-02-23       Impact factor: 2.374

2.  The accuracy and utility of contrast-enhanced MR angiography for localization of spinal dural arteriovenous fistulas: the Toronto experience.

Authors:  Arjen Lindenholz; Karel G TerBrugge; J Marc C van Dijk; Richard I Farb
Journal:  Eur Radiol       Date:  2014-07-12       Impact factor: 5.315
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.